medmix AG (MEDX)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 23 Oct 2026
Key indicators
| Last close | CHF 10.48 |
|---|---|
| 52-week range | 7.61 – 12.36 |
| Return, 1 month / 3 months | +6.1% / +32.7% |
| Return, 1 year / 3 years | +7.5% / −43.2% |
| Trend | Uptrend |
| RSI (14) | 69 |
| Volatility (1 year) | 31.2% |
| Worst drawdown (1 year) | -34.1% |
| Average daily value traded | 0.64M CHF |
| Dividend yield | 1.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
medmix AG designs and manufactures precision delivery devices for mixing, dispensing and applying materials. Its products include dental mixing tips and syringes, applicators for beauty and personal care products, and dispensing systems used in healthcare and industrial adhesives. Customers are dental professionals, healthcare and cosmetics companies, and industrial manufacturers who need controlled, repeatable delivery of two-component materials. The company is based in Switzerland and supplies customers in many countries around the world.
medmix AG trades under the code MEDX on the SIX Swiss Exchange in Switzerland, with its price quoted in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
medmix AG (MEDX) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 10.48 on 23 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 118 of 226 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.5% and over the last three months it rose 32.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 12.7% | ||
| From 52-week high | -13.2% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 32.7% | ||
| 6-month return | 20.3% | ||
| 12-month return, skipping the last month | 1.3% | ||
| Stability (higher is calmer) | 37 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.1% | ||
| Liquidity | 42 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.64M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 33 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.0% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +4.2% |
|---|---|
| 1 month | +6.1% |
| 3 months | +32.7% |
| 6 months | +20.3% |
| 1 year | +7.5% |
| 3 years | −43.2% |
| 5 years | −72.8% |
Signals
| 50-day / 200-day average | 9.41 / 9.30 |
|---|---|
| Golden / death cross (60 days) | Golden, 4 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.27 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Apr 2026 | CHF 0.1000 |
| 25 Apr 2025 | CHF 0.5000 |
| 26 Apr 2024 | CHF 0.5000 |
| 3 May 2023 | CHF 0.5000 |
| 14 Apr 2022 | CHF 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.